Advertisement

Topics

FDA clears Pfizer's leukaemia drug Besponsa

06:19 EDT 21 Aug 2017 | PMLIVE

The breakthrough treatment is the first CD22-targeted ADC to be approved in the US

Original Article: FDA clears Pfizer's leukaemia drug Besponsa

NEXT ARTICLE

More From BioPortfolio on "FDA clears Pfizer's leukaemia drug Besponsa"

Advertisement
Quick Search
Advertisement
Advertisement